Receiving Modified Chemotherapy Followed With Radical Resection After Neoadjuvant Chemotherapy

Summary

For patients undergoing postoperative therapy for locally advanced gastric cancer after neoadjuvant chemotherapy, we assessed the utility of graded histologic regression of \<50% as the criterion of treatment change. Sixty patients will be enrolled to randomize into two groups：receiving modified chemotherapy and receiving the original chemotherapy.

Timeline

Start

2017-08-23

Primary completion

2022-08

Completion

2023-08

Drugs

Indications